Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders

Clinical trial NCT00773812 · COMPLETED

Trial details

NCT number: NCT00773812
Sponsor: Ohio State University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autistic Disorder Pervasive Developmental Disorder

Start date: 2007-07-01
Primary completion: 2012-11-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.